Literature DB >> 21352865

Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV 2 exposure and infection in swine finisher herds.

Sumathy Puvanendiran1, Suzanne Stone, Wanqin Yu, Craig R Johnson, Juan Abrahante, Liza Garcia Jimenez, Theodor Griggs, Charles Haley, Bruce Wagner, Michael P Murtaugh.   

Abstract

Porcine circovirus (PCV) appeared in 1974 as an unidentified, innocuous viral inhabitant of cell cultures and pigs. Today PCV1 is a contaminant of some human vaccines, and PCV2 is a major pathogen of swine. PCV1 is reportedly ubiquitous in swine but nonpathogenic. Since the interplay of PCV1 and PCV2 in swine might explain variable disease results and shed light on the potential for human exposure, we analyzed in depth the prevalence of PCV1 and PCV2 infection and exposure in the U.S. finishing swine herd. Over 82% of sera from 185 farms were positive for PCV2 by PCR, whereas only 2.4% were positive for PCV1. More than 80% of PCV2 DNA-positive swine were also positive for anti-PCV2 antibodies. PCV1 was only rarely present. Exposure of swine, and therefore humans via pigs, to PCV1 is negligible. We conclude that PCV2 causes a persistent infection in pigs and that PCV1 is absent or rare in swine.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352865     DOI: 10.1016/j.virusres.2011.02.012

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  12 in total

1.  Risk Assessment for Use of a Porcine Circovirus-Contaminated Reagent in a Barrier Maintained Rodent Colony.

Authors:  Norman C Peterson; Aaron A Berlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-30       Impact factor: 1.232

2.  The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2.

Authors:  Peter D Burbelo; Jack A Ragheb; Amit Kapoor; Yanjin Zhang
Journal:  Biologicals       Date:  2013-10-10       Impact factor: 1.856

3.  Development and application of a double-antigen sandwich enzyme-linked immunosorbent assay for detection of antibodies to porcine circovirus 2.

Authors:  Meng Ge; Wei Luo; Daliang Jiang; Runcheng Li; Wenwei Zhao; Guoliang Chen; Xingdong Yang; Xinglong Yu
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

4.  Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®.

Authors:  Mathew D Esona; Slavica Mijatovic-Rustempasic; Catherine Yen; Umesh D Parashar; Jon R Gentsch; Michael D Bowen; Philip LaRussa
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

5.  Outcome of experimental porcine circovirus type 1 infections in mid-gestational porcine foetuses.

Authors:  Dipongkor Saha; David J Lefebvre; Richard Ducatelle; Jan V Doorsselaere; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2011-10-21       Impact factor: 2.741

6.  PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.

Authors:  Hanna C Koinig; Stephanie C Talker; Maria Stadler; Andrea Ladinig; Robert Graage; Mathias Ritzmann; Isabel Hennig-Pauka; Wilhelm Gerner; Armin Saalmüller
Journal:  Vet Res       Date:  2015-03-03       Impact factor: 3.683

7.  An indirect enzyme-linked immunosorbent assay for the identification of antibodies to Senecavirus A in swine.

Authors:  Cheryl M T Dvorak; Zeynep Akkutay-Yoldar; Suzanne R Stone; Steven J P Tousignant; Fabio A Vannucci; Michael P Murtaugh
Journal:  BMC Vet Res       Date:  2017-02-15       Impact factor: 2.741

Review 8.  Possible risks posed by single-stranded DNA viruses of pigs associated with xenotransplantation.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Xenotransplantation       Date:  2018-07       Impact factor: 3.907

9.  Development of a multiplex PCR to detect and discriminate porcine circoviruses in clinical specimens.

Authors:  Keli Yang; Zuwu Jiao; Danna Zhou; Rui Guo; Zhengying Duan; Yongxiang Tian
Journal:  BMC Infect Dis       Date:  2019-09-05       Impact factor: 3.090

10.  Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing.

Authors:  Marine Dumarest; Erika Muth; Justine Cheval; Marlène Gratigny; Charles Hébert; Léa Gagnieur; Marc Eloit
Journal:  Biologicals       Date:  2014-11-15       Impact factor: 1.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.